St. Antonius Ziekenhuis — Clinical Trial Site

85 Registered trials

43 Currently recruiting

Organisation

St. Antonius Ziekenhuis

Location

Nieuwegein, Netherlands

Identifier

ORG-100023243

Address

Soestwetering 1, 3543 AZ, Netherlands

Departments

#1705:Cardiology
#8001: Pulmonology
02-038:Hematologie
1901: Lung diseases
801: Pulmonology - Oncology
Cardiology
Department of Neurology
Department of Nuclear Medicine
Department of Oncology
Department of Pulmonology
Department of Surgery
Dept Cardiology - Nieuwegein
Gastroenterology
Gastroenterology and Hepatology
Gynaecology
Hematologie
Hematology
HPB surgery
internal diseases
Internal Medicine
Internal medicine, Hematology
Internal Medicine/Oncology
Interne Geneeskunde
Interne geneeskunde, Medische Oncologie
Interventional Cardiology
Longziekten - St. Antonius Ziekenhuis / Lung Diseases St. Anthony Hospital
Loongziekten
Lung oncology
Medical oncology
medische oncologie
N/A
NA
Neurology
Oncologie
Oncology
Orthopedic surgery
Parent
Pediatrics
Pneumology
Pulmonary diseases
Pulmonology
St. Antonius Ziekenhuis
Surgery
Urology

Clinical trials at this site (85)

Search interface

Transplant BRaVE NHL: Phase I-II study combining Brentuximab Vedotin with second line salvage chemotherapy (R-DHAP) in CD30 positive diffuse… Ended

2023-510556-22-00 non-Hodgkin lymphoma (NHL) 4 2018-03-05
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) Ended

2023-508606-26-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2015-04-23
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the tr… Ended

2023-506185-31-00 Idiopathic pulmonary fibrosis (IPF) 10 2024-07-18
Individualized anti-platelet therapy in patients with stable coronary artery disease undergoing stenting Ended

2023-504078-39-01 Stable coronary artery disease 6 2024-01-11
Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended

2023-504205-36-00 Aortic stenosis 11 2023-11-01
Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: a randomized controlled… Ended

2023-504817-56-00 Bronchiolitis 6 2023-09-05
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE study) Ended

2022-501783-18-00 Parkinson’s Disease 4 2023-07-21
A study of efficacy and safety of various treatments in participants with idiopathic pulmonary fibrosis (IPF) Ended

2023-508729-28-00 Idiopathic pulmonary fibrosis 4 2023-04-25
A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous efzofitimod in patients wit… Ended

2023-506039-13-00 pulmonary sarcoidosis 5 2023-04-12
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathi… Ended

2024-515964-30-00 Interstitial Lung Diseases (ILD), including but not lim 4 2021-07-14
Investigation to assess the effects of zalunfiban in patients with an acute heart attack Ended

2023-508485-15-00 Subjects with documented STEMI, presenting with persist 5 2021-04-22
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit… Ended

2023-508443-40-00 Lung Cancer, Non-Small Cell 5 2020-12-18